Life Time Group Holdings heads into mid-August with a sharp divide between a buoyant analyst community and an executive suite quietly taking chips off the table.
The Street reaction to the most recent results was unambiguous. Following the July 30 earnings print — which nudged the stock down just 1.3% on the day and 4.9% over the following five sessions — analysts responded with a wave of target increases. UBS raised its target from $43 to $57 while keeping its Buy rating. RBC lifted to $60, Mizuho moved to $64, and Wells Fargo pushed to $51. The consensus mean target now sits at roughly $54, about 23% above the current price of $43.81. The analyst recommendation differential factor ranks in the 94th percentile — meaning the Street's collective conviction in LTH is extraordinarily high relative to the broader market. EPS momentum is also running well, with 30-day and 90-day ranks of 73 and 68 respectively. The bull case rests on membership growth accelerating toward 5% annually, per-member spending rising ~6%, and a club expansion pipeline that shifts the revenue mix toward higher-margin memberships. The bear case acknowledges that at roughly 13.4x EV/EBITDA the stock has re-rated meaningfully — still at a discount to some leisure peers, but no longer cheap.
The insider story complicates the bullish narrative. On July 31 — the same day analysts were raising targets — the founder and CEO Bahram Akradi sold approximately 438,000 shares near $45, and the CFO, Chief Administrative Officer, and a division president also sold in the same session, with the CAO alone offloading nearly $21.6 million worth of stock. Net insider disposals over the past 90 days total roughly 16.6 million shares, worth more than $524 million. Some of that reflects a Leonard Green & Partners block sold in early June at $28.60 when the stock was much lower, so the mix of motivated sellers spans private equity exits and management monetisation. None of the recent trades are coded as distressed or unusual in timing — all the July 31 sales appear to be systematic — but the scale is notable and contrasts sharply with the bullish analyst tone.
Positioning in the lending market tells a relaxed story. Short interest has actually been declining — it fell roughly 2.7% on the week to 4.3% of free float, down from above 5% in mid-July. Borrow availability is exceptionally loose at over 2,000%, meaning there are more than twenty shares available for every one currently on loan. Cost to borrow has ticked up 27% on the week to 0.48%, but that is still a very low absolute level, consistent with a name where bearish conviction remains limited. The ORTEX short score sits at 40 — squarely mid-range — and has barely moved in either direction over the past two weeks.
Options activity has eased off notably bearish levels. The put/call ratio has dropped to 3.56, down from a 52-week high of 6.58 hit on July 29 — the eve of earnings. The current reading is modestly below the 20-day average of 4.09, suggesting the heavy demand for downside protection that built ahead of the print has unwound. The z-score of -0.32 confirms the move is within normal range. Among correlated peers, BLMN surged nearly 25% on the week and TXRH added 0.8%, while RCL slipped 5.7% — a mixed leisure tape that did not obviously drag or lift LTH, which ended the week down 2.1%.
The stock is up roughly 4.6% on the month and has posted a striking year-to-date run of close to 60% — a move that has drawn BlackRock to 10.1% of shares and seen T. Rowe Price add over 2.4 million shares to reach 3.7%. With no next earnings date yet confirmed, what to watch is whether the insider selling pace moderates as the stock hovers in the low $40s, and whether the wide gap between the analyst consensus target and the current price draws fresh institutional accumulation or simply reflects a Street that got ahead of the fundamentals.
See the live data behind this article on ORTEX.
Open LTH on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
